SFRP1 and neoplasm: While most studies have examined SFRP1 in tumor tissue or cell lines, recent research has demonstrated the utility of a cfDNA-based liquid biopsy approach for examining promoter hypermethylation of SFRP1 (phSFRP1) and assessing prognosis in patients with PDAC (22–24).